← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2008Last known activity
May 26, 2023
Timeline
2000s
- Jan 1, 2008
Fundacion SEIMC-GESIDA— Founded
Drugs by trial phase (23 distinct, 20 trials)
Phase 4 (21 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT05898841Lead sponsorPhase 4May 26, 2023
- NCT05549180Lead sponsorPhase 4Sep 27, 2022
- NCT05405751Lead sponsorPhase 4Jun 15, 2022
- NCT04884139Lead sponsorPhase 4Jul 1, 2021
- NCT04880785Lead sponsorPhase 2Jun 1, 2021
- NCT04445272Lead sponsorPhase 2May 22, 2020
- NCT04076423Lead sponsorPhase 4Sep 15, 2019
- NCT03685500Lead sponsorPhase 4Oct 15, 2018
- NCT03626467Lead sponsorPhase 4Sep 15, 2018
- NCT03693508Lead sponsorPhase 4Apr 13, 2018
- NCT03067285Lead sponsorPhase 4Jul 1, 2017
- NCT03105349Lead sponsorPhase 4May 15, 2017
- NCT02159599Lead sponsorPhase 4Jul 1, 2014
- NCT01946009Lead sponsorN/ASep 1, 2013
- NCT01303549Lead sponsorPhase 4Nov 1, 2011
Details
- Founded
- Madrid, ES Jan 1, 2008
- Last known activity
- May 26, 2023